Persistent Systems Ltd.

Persistent Systems, the global leader in software product and technology services and Bio-Modeling Systems (BMSystems), a leading integrative systems biology company has entered into a joint systems biology research and development initiative.

The strategic initiative is the world's first collaborative effort that marries non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development by pharmaceutical and cosmetic industries. A key deliverable of this joint initiative is the development of a predictive in silico or computer simulated skin model that will help eliminate the need to use animals in contact allergy testing. Today's announcement follows on the heels of the European Union's ban on the import and sale of cosmetics containing ingredients tested on animals, offering the industry a highly effective and essential alternative.

Bio-Modeling Systems' team of highly skilled biologists will combine the outputs of its CAD proprietary heuristic modeling platform with a powerful new software platform, Cell-in-Silico, developed by Persistent, resulting in the first heuristic model of skin cell interplay mechanisms to be enhanced through mathematical modeling. This strategic collaboration harnesses the scientific and bioinformatics capabilities of Bio-Modeling Systems and the information technology and scientific capabilities of Persistent Systems to provide the first ever truly holistic systems-based drug discovery solutions.

Persistent Systems is an OPD specialty company, offering the customers the benefits of offshore delivery. It designs, develops and maintains software systems and solutions, creates new applications and enhances the functionality of the customers’ existing software products. It delivers services across all stages of the product life-cycle, which enables it to work with a wide-range of customers and allows it to develop, enhance and deploy its customers’ software products.